CITADEL ADVISORS LLC 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
CITADEL ADVISORS LLC | 2,084,267 7.800% |
-8,221 (-0.39%) |
Filing |
| 2023-11-17 4:23 pm Purchase |
2023-11-07 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
CITADEL ADVISORS LLC | 2,092,488 8.300% |
2,092,488 (New Position) |
Filing |